Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.verified




Market Cap:


Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti...[Read more]



IPO Date


Stock Exchange




The PE Ratio as of June 2024 (TTM) for Sorrento Therapeutics, Inc. (SRNE) is -0.01

According to Sorrento Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -98.73% compared to the average of -0.79 of the last 4 quarters.

Sorrento Therapeutics, Inc. (SRNE) Historical PE Ratio (quarterly & annually)

How has SRNE PE Ratio performed in the past?

The mean historical PE Ratio of Sorrento Therapeutics, Inc. over the last ten years is -0.69. The current -0.01 PE Ratio has changed 45.40% with respect to the historical average. Over the past ten years (40 quarters), SRNE's PE Ratio was at its highest in in the March 2021 quarter at 231.13. The PE Ratio was at its lowest in in the September 2015 quarter at -83.38.

Quarterly (TTM)









Sorrento Therapeutics, Inc. (SRNE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sorrento Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 284.35%

Maximum Annual PE Ratio = 29.02

Minimum Annual Increase = -816.49%

Minimum Annual PE Ratio = -7.75

Quarterly (TTM)
YearPE RatioChange

Sorrento Therapeutics, Inc. (SRNE) Average PE Ratio

How has SRNE PE Ratio performed in the past?

The current PE Ratio of Sorrento Therapeutics, Inc. (SRNE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Sorrento Therapeutics, Inc. (SRNE) PE Ratio vs. Peers

How is SRNE’s PE Ratio compared to its peers?

Sorrento Therapeutics, Inc.’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Sorrento Therapeutics, Inc. (SRNE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sorrento Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sorrento Therapeutics, Inc. (SRNE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sorrento Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sorrento Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Sorrento Therapeutics, Inc. (SRNE)?

What is the highest PE Ratio for Sorrento Therapeutics, Inc. (SRNE)?

What is the 3-year average PE Ratio for Sorrento Therapeutics, Inc. (SRNE)?

What is the 5-year average PE Ratio for Sorrento Therapeutics, Inc. (SRNE)?

How does the current PE Ratio for Sorrento Therapeutics, Inc. (SRNE) compare to its historical average?